Results 1 -
8
of
8
for
Olutasidenib
- Olutasidenib is used to treat a certain type of acute myeloid leukemia (AML; a type of cancer ... or that has not improved after previous treatment(s). Olutasidenib is in a class of medications called IDH1 ...
- Cancer/Treatments and Therapies ... Cancer ... Cancer Chemotherapy/Start Here ... Cancer Chemotherapy ... National Cancer Institute ... From the National Institutes of Health ... List ...
- Leukemia/Treatments and Therapies ... Leukemia ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved by the FDA ...
- Find out what's new in current leukemia research including progress on targeted therapies and immunotherapies, and NCI programs and clinical trials. ... Acute ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)
Medicines/Statistics and Research ... Medicines ... Liver Diseases/Statistics and Research ... Liver Diseases ... LiverTox® provides regularly updated, unbiased and easily ... - Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... The LactMed® database contains information on drugs and other chemicals ...
- What's New in Acute Myeloid Leukemia (AML) Research? (American Cancer Society)Acute Myeloid Leukemia/Statistics and Research ... Acute Myeloid Leukemia ... American Cancer Society ... Study of causes, prevention, and treatment of AML is ongoing ...
- If Acute Myeloid Leukemia (AML) Doesn't Respond or Comes Back after Treatment (American Cancer Society)Acute Myeloid Leukemia/Treatments and Therapies ... Acute Myeloid Leukemia ... American Cancer Society ... If acute myeloid leukemia (AML) continues to grow or returns ...